Dr. Hu, Yu-Feng ’s Lab胡瑜峰 博士 實驗室

HIGHLIGHT DETAIL
重要成果詳細內容


Fibroblasts Drive Metabolic Reprogramming in Pacemaker Cardiomyocytes

Circulation Research, Jun 24, 2022

 

 

 

Methods: Tbx18 (T-box transcription factor 18)-induced PCs and fibroblasts were used for cocultures and engineered tissues, which were used as the in vitro models to explore how fibroblasts regulate the functional integrity of SANs. RNA-sequencing, metabolomics, and cellular and molecular techniques were applied to characterize the molecular signals underlying metabolic reprogramming and identify its critical regulators. These pathways were further validated in vivo in rodents and induced human pluripotent stem cell-derived cardiomyocytes.

Conclusions: Fibroblasts drive Aldoc-mediated metabolic reprogramming and rhythmic regulation in SANs. This work details the cellular machinery behind the complex milieu of vertebrate SANs and opens a new direction for future therapy.

Journal Link 期刊連結



Top